Community registry for cancer risk assessment and prevention
Official title: CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
Run by Hackensack Meridian Health · NCT06804395 · Data updated 2026-11-12
This study is collecting information from adults at higher risk for cancer to see how we can improve cancer screening and prevention in the community.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Hackensack Meridian Health Academic / other |
| Locations | 1 site (Totowa, New Jersey) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | October 1, 2034 |
| Study ends | October 1, 2034 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT06804395 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with a personal or family history indicating an increased risk for cancer.
✕Probably not a fit
Patients without any known risk factors for cancer or those who do not meet the eligibility criteria may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data from adults at increased risk for cancer to enhance understanding of cancer screening and diagnostics. Participants complete questionnaires and provide consent for data collection related to their cancer risk. The initiative is led by the HMH Hennessey Institute for Cancer Prevention and Applied Molecular Science, aiming to improve early cancer detection and management in the community. By gathering this information, the registry seeks to facilitate better cancer prevention strategies and outcomes.
Why it matters
Potential benefit: If successful, this initiative could lead to improved early detection and management of cancer, ultimately enhancing patient outcomes.
How similar studies have gone: Other studies focusing on community-based cancer screening and risk assessment have shown promise in improving early detection rates.
Who can join: the full rules
Show full inclusion / exclusion criteria
* Adults ( 18 and older) * Ability to provide own consent * Must meet at least one of the below criteria, Indicating an increased risk for cancer, any of the following: * Family or personal history suggests a familial/hereditary disorder known or suspected of predisposition to cancer. * Personal factors associated with an increased risk for cancer include benign breast disease, polyps, tobacco use, etc.as defined by the investigator. * Family members of participating individuals. * Any participant in the HICAP program regardless of cancer risk
Where it's running
-
Hennessy Institute for Cancer Prevention and Applied Molecular Medicine
Totowa, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Elias Obeid, MD, MPH — Hackensack Meridian Health
- Study coordinator: Lee Ifhar, MSc, CCRP
- Email: Lee.ifhar@hmhn.org
- Phone: 862-657-4227
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oncology biobank and longitudinal sample collection at NYCBS
This collects and stores blood, tissue, and health information from adults with cancer, people at higher risk, and healthy donors to help researchers test new cancer tests and treatments.
-
AI (Mirai)-guided supplemental MRI to find breast cancer in women at high Mirai risk
This will test whether adding a screening breast MRI finds more cancers in women whose mammograms are flagged as high risk by the Mirai AI model.
-
Collecting data to predict cancer risk in at-risk populations
This study is trying to collect samples and health information from people at higher risk of cancer to see if they can find signs that help predict cancer early on.
-
A program to improve cancer care for the community
This study is trying to improve cancer care for African American patients by collecting health information and biological samples to help develop better treatments tailored to their needs.
-
A program to collect cancer-related samples and data for better cancer care
This study is collecting blood, tissue, and other samples from people with cancer or at risk of it to help improve cancer care and treatment in the future.
-
Partnership with patients at risk of cancer
This study is collecting blood, tissue, and other samples from cancer patients and those at risk to see how it can help improve cancer care and support future research.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.